Azathioprine, cyclophosphamide and chlorambucil. by Luqmani, R, Palmer, R, Bacon, P

Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease. by Luqmani, R, Gordon, C, Bacon, P

Treatment of vasculitis in rheumatoid arthritis. by Luqmani, R, Watts, R, Scott, D, Bacon, P

Undiagnosed systemic lupus erythematosus in the community. by Johnson, A, Gordon, C, Hobbs, R, Bacon, P

Disease assessment and management of the vasculitides. by Luqmani, R, Exley, A, Kitas, G, Bacon, P

Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials by Luqmani, R, Bacon, P, Rasmussen, N, Jayne, D

Validation of the Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials. by Luqmani, R, Bacon, P, Rasmussen, N, Jayne, D

Cyclophosphamide and systemic vasculitis. by Luqmani, R, Moots, R, Emery, P, Bacon, P, Adu, D

VITAL (Vasculitis Integrated Assessment Log) assessment of vasculitis. by Bacon, P, Moots, R, Exley, A, Luqmani, R, Rasmussen, N

Functional outcome vs damage in systemic vasculitis by Exley, A, Carruthers, D, Kitas, G, Luqmani, R, Bacon, P

FUNCTIONAL ASSESSMENT IN VASCULITIS USING THE SF-36 by Exley, A, Moots, R, Carruthers, D, Luqmani, R, Bacon, P

A Novel Web Based Rheumatology Educational Resource: Interactive Computerised Case Studies for Undergraduate Teaching by Wilson, A, Llewellyn, P, Bowman, S, Harris, S, Nixon, M, Bacon, P, Young, S

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE by Moots, R, Young, S, Strominger, J, Frelinger, J, Bacon, P, Mcmichael, A

INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE by Moots, R, Young, S, Strominger, J, Frelinger, J, Bacon, P, Mcmichael, A

Electronic Self Assessment Data Gathering in Rheumatology Clinics by Wilson, A, Kitas, G, Carruthers, D, Reay, C, Young, S, Harris, S, Bacon, P

The association of HLA DR beta alleles with self-limiting and persistent forms of early symmetrical polyarthritis. by Salmon, M, Wordsworth, P, Emery, P, Tunn, E, Bacon, P, Bell, J

Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). by Exley, A, Bacon, P, Luqmani, R, Kitas, G, Carruthers, D, Moots, R

Genetically determined factors as predictors of radiological change in patients with early symmetrical arthritis. by Emery, P, Salmon, M, Bradley, H, Wordsworth, B, Tunn, E, Bacon, P, Waring, R

THE VASCULITIS DAMAGE INDEX (VDI) by Exley, A, Banbury, P, Carruthers, D, Moots, R, Luqmani, R, Kitas, G, Bacon, P

Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. by Exley, A, Bacon, P, Luqmani, R, Kitas, G, Gordon, C, Savage, C, Adu, D